TRAITEMENT PAR ÉPLÉRÉNONE DANS LA CHORIORÉTINITE SÉREUSE CENTRALE CHRONIQUE : À PROPOS DE 8 CAS

TRAITEMENT PAR ÉPLÉRÉNONE DANS LA CHORIORÉTINITE SÉREUSE CENTRALE CHRONIQUE : À PROPOS DE 8 CAS

Introduction :La choriorétinite séreuse centrale est une affection oculaire relativement fréquente. Il s’agit d’une maculopathie du sujet jeune, caractérisée par la présence d’un décollement séreux rétinien (DSR) siégeant habituellement au pôle postérieur, associé à des modifications de l’épithélium...

Full description

Bibliographic Details
Main Authors:	A. El ouafi, F. EL alami, A. Bouzidi, A. Boussel, S. Iferkhass, A. Laktaoui
Format:	Article
Language:	English
Published:	Societé Marocaine d’Ophtalmologie 2019-06-01
Series:	Journal de la Société Marocaine d’Ophtalmologie
Subjects:	choriorétinite séreuse centrale chronique, éplérénone, liquide sous rétinien, récepteurs aux minéralocorticoides.
Online Access:	https://revues.imist.ma/index.php/JSMO/article/view/19135

Similar Items

Ceci n´est pas une choriorétinite séreuse centrale!
by: Kenza Benouhoud, et al.
Published: (2020-09-01)

Choriorétinite cicatricielle bilatérale chez une fille de 05 ans : Séquelles de toxoplasmose congénitale ?
by: JML Tiama, et al.
Published: (2020-11-01)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
by: Kapil G. Kapoor, et al.
Published: (2015-12-01)

Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study
by: Hamid-Reza Moein, et al.
Published: (2019-09-01)

Choriorétinite toxoplasmique active de l’œil droit chez une adolescente à propos d’un cas
by: Diallo S
Published: (2018-11-01)

Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology
by: Sofia S. Pereira, et al.
Published: (2021-04-01)

Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses
by: Fernet M, et al.
Published: (2018-09-01)

Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial
by: Subha V. Raman, et al.
Published: (2017-02-01)

Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division
by: Andrea Vecchiola, et al.
Published: (2020-04-01)

Eplerenone versus placebo for chronic central serous chorioretinopathy: the VICI RCT
by: Andrew Lotery, et al.
Published: (2021-01-01)

Maladie de Von Hippel-Lindau : A propos de 2 cas
by: MEH Meskini, et al.
Published: (2015-05-01)

Le décollement de rétine : Aspects échographiques
by: N Moussali, et al.
Published: (2013-05-01)

EVIDENCE-BASED USE OF EPLERENONE
by: S. R. Gilyarevski, et al.
Published: (2014-07-01)

EVIDENCE-BASED USE OF EPLERENONE
by: S. R. Gilyarevski, et al.
Published: (2014-07-01)

A Prospective Study of Eplerenone in the Treatment of Patients with Glomerulonephritis
by: Marios Papasotiriou, et al.
Published: (2023-12-01)

Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
by: Mario Boehm, et al.
Published: (2018-03-01)

Effects of eplerenone on cerebral aldosterone levels and brain lesions in spontaneously hypertensive rats
by: Xue Wang, et al.
Published: (2020-08-01)

MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
by: V. N. Soboleva, et al.
Published: (2015-01-01)

Dexamethasone-associated metabolic effects in male mice are partially caused by depletion of endogenous corticosterone
by: Lisa L. Koorneef, et al.
Published: (2022-08-01)

Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research
by: Argen Mamazhakypov, et al.
Published: (2023-01-01)

Mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy: systematic review and meta-analyses
by: Camila Q. Felipe, et al.
Published: (2022-06-01)

Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature
by: Irini Chatziralli, et al.
Published: (2018-09-01)

Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece
by: Athanasakis K, et al.
Published: (2016-10-01)

Dissecting the Effects of Aldosterone and Hypokalemia on the Epithelial Na+ Channel and the NaCl Cotransporter
by: Mathias Kristensen, et al.
Published: (2022-04-01)

MACROANÉVRYSME ARTÉRIEL RÉTINIEN COMPLIQUÉ D’UNE MACULOPATHIE EXSUDATIVE
by: B Serraj Andaloussi, et al.
Published: (2016-05-01)

Hémorragie cérébelleuse à distance après évacuation d'un hématome sous dural chronique par trou de trépan
by: Abdelkarim Shimi, et al.
Published: (2015-04-01)

Formulation and Characterization of Eplerenone Nanoemulsion Liquisolids, An Oral Delivery System with Higher Release Rate and Improved Bioavailability
by: Ahmed Khames
Published: (2019-01-01)

Pharmacokinetic study of eplerenone in rats after long-term coadministration with buckwheat tea
by: Liang Zou, et al.
Published: (2016-04-01)

Caveolin 1 Modulates Aldosterone‐Mediated Pathways of Glucose and Lipid Homeostasis
by: Rene Baudrand, et al.
Published: (2016-10-01)

PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY
by: O. M. Drapkina, et al.
Published: (2017-09-01)

New Clinical Aspects of Eplerenone Use in Clinical Practice
by: S. R. Gilyarevskiy, et al.
Published: (2018-09-01)

Possible dose-dependent effect of eplerenone on intraocular pressure
by: Seyedeh Mehrsa Sadat Razavi, et al.
Published: (2023-01-01)

Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone
by: William J. Anderson, et al.
Published: (2022-12-01)

Oral eplerenone for treatment of bullous retinal detachment secondary to chronic central serous retinopathy
by: Prachi Abhishek Dave, et al.
Published: (2017-01-01)

Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone – a case report
by: Ramesh Venkatesh, et al.
Published: (2020-06-01)

Rational drug therapy of chronic heart failure: the role of mineralocorticoid receptor antagonists: review
by: Natalia V. Safronova, et al.
Published: (2022-01-01)

Mineralocorticoid receptor antagonists in chronic central serous chorioretinopathy
by: Ana Sanhueza, et al.
Published: (2020-09-01)

Tunisie 2019 : Chronique d’une surprise électorale annoncée
by: Eric Gobe
Published: (2020-12-01)

Effective Ocular Delivery of Eplerenone Using Nanoengineered Lipid Carriers in Rabbit Model
by: Abdelhakeem E, et al.
Published: (2021-07-01)

Ostéomyélite chronique primitive de la mandibule
by: Mohamed Sahli, et al.
Published: (2020-09-01)